Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U3 small nucleolar RNA-associated protein 18 homolog (UTP18) is a core component of the small subunit (SSU) processome, a nucleolar ribonucleoprotein complex required for the assembly and processing of the precursor to the small (18S) ribosomal RNA subunit in eukaryotes. It contains the WD40 repeat domain, which acts as a scaffold for multiprotein complex assembly but lacks catalytic activity. UTP18 enables RNA binding and contributes to the coordinated folding, modification, cleavage, and degradation of pre-rRNA during the maturation of ribosomal subunits. The gene is implicated in ribosomal biogenesis and nucleolar structure, with genetic variations associated with diseases such as Spinocerebellar Ataxia 13. There is no evidence for therapeutic targeting, drug interactions, or established biomarker/safety information in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U3 small nucleolar RNA-associated protein 18 homolog (UTP18).